Vimta Labs Limited (VIMTALABS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vimta Labs Limited (VIMTALABS) has a cash flow conversion efficiency ratio of 0.180x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs748.73 Million ≈ $8.10 Million USD) by net assets (Rs4.16 Billion ≈ $45.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Vimta Labs Limited (VIMTALABS) net asset quality to measure how much of total assets are equity-financed.
Vimta Labs Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Vimta Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Vimta Labs Limited to evaluate the quality of earnings relative to operating cash generation.
Vimta Labs Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vimta Labs Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cogstate Ltd
AU:CGS
|
0.235x |
|
Ive Group Ltd
AU:IGL
|
0.158x |
|
Tellgen Corp
SHE:300642
|
0.025x |
|
Experian PLC
LSE:EXPN
|
0.251x |
|
Tanzanian Royalty Exploration Corp
NYSE MKT:TRX
|
0.039x |
|
Nanjing Chervon Auto Precision Technology Co Ltd
SHG:603982
|
0.065x |
|
Gérard Perrier Industrie S.A.
PA:PERR
|
0.163x |
|
Trigold Holdings Ltd
TWO:3709
|
0.727x |
Annual Cash Flow Conversion Efficiency for Vimta Labs Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Vimta Labs Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Vimta Labs Limited (VIMTALABS) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs3.79 Billion ≈ $40.97 Million |
Rs948.30 Million ≈ $10.26 Million |
0.250x | +31.42% |
| 2024-03-31 | Rs3.20 Billion ≈ $34.57 Million |
Rs608.92 Million ≈ $6.59 Million |
0.190x | -38.97% |
| 2023-03-31 | Rs2.82 Billion ≈ $30.47 Million |
Rs879.37 Million ≈ $9.51 Million |
0.312x | +23.62% |
| 2022-03-31 | Rs2.34 Billion ≈ $25.30 Million |
Rs590.69 Million ≈ $6.39 Million |
0.252x | +31.98% |
| 2021-03-31 | Rs1.94 Billion ≈ $21.02 Million |
Rs371.82 Million ≈ $4.02 Million |
0.191x | +35.82% |
| 2020-03-31 | Rs1.73 Billion ≈ $18.70 Million |
Rs243.48 Million ≈ $2.63 Million |
0.141x | -38.28% |
| 2019-03-31 | Rs1.72 Billion ≈ $18.55 Million |
Rs391.46 Million ≈ $4.23 Million |
0.228x | +4.81% |
| 2018-03-31 | Rs1.52 Billion ≈ $16.44 Million |
Rs331.05 Million ≈ $3.58 Million |
0.218x | +23.92% |
| 2017-03-31 | Rs1.36 Billion ≈ $14.72 Million |
Rs239.20 Million ≈ $2.59 Million |
0.176x | +2276.78% |
| 2016-03-31 | Rs1.26 Billion ≈ $13.64 Million |
Rs-10.18 Million ≈ $-110.07K |
-0.008x | -106.45% |
| 2015-03-31 | Rs1.22 Billion ≈ $13.23 Million |
Rs153.06 Million ≈ $1.66 Million |
0.125x | -10.34% |
| 2014-03-31 | Rs1.20 Billion ≈ $13.02 Million |
Rs168.00 Million ≈ $1.82 Million |
0.140x | +1.10% |
| 2013-03-31 | Rs1.12 Billion ≈ $12.15 Million |
Rs155.03 Million ≈ $1.68 Million |
0.138x | +16.97% |
| 2012-03-31 | Rs1.10 Billion ≈ $11.86 Million |
Rs129.39 Million ≈ $1.40 Million |
0.118x | +77.91% |
| 2011-03-31 | Rs1.25 Billion ≈ $13.52 Million |
Rs82.93 Million ≈ $896.82K |
0.066x | -64.58% |
| 2010-03-31 | Rs1.31 Billion ≈ $14.14 Million |
Rs244.77 Million ≈ $2.65 Million |
0.187x | +1.40% |
| 2009-03-31 | Rs1.30 Billion ≈ $14.07 Million |
Rs240.30 Million ≈ $2.60 Million |
0.185x | +83.97% |
| 2008-03-31 | Rs1.28 Billion ≈ $13.86 Million |
Rs128.64 Million ≈ $1.39 Million |
0.100x | +418.23% |
| 2007-03-31 | Rs1.24 Billion ≈ $13.41 Million |
Rs24.01 Million ≈ $259.70K |
0.019x | -88.04% |
| 2006-03-31 | Rs1.17 Billion ≈ $12.69 Million |
Rs189.93 Million ≈ $2.05 Million |
0.162x | -- |
About Vimta Labs Limited
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more